In 2006, Dr. Bolzern founded PharmaZell via an MBO, creating a company focused on the production of pharmaceutical active ingredients (API) for the pharma industry, headquartered in Raubling, Germany. As CEO, he grew the company into four production sites in Europe and India with almost 1000 employees and a turnover of over EUR 200 million. After 15 years at PharmaZell – including four years as CEO of both companies Treemera and PharmaZell – he left PharmaZell to concentrate fully on the management of Treemera.

Dr. Oliver Bolzern earned his Ph.D. as a chemical engineer at the ETH Zurich, Switzerland.